key: cord-0974735-w84g6ch6 authors: Umair, Massab; Ikram, Aamer; Salman, Muhammad; Alam, Muhammad Masroor; Badar, Nazish; Rehman, Zaira; Tamim, Sana; Khurshid, Adnan; Ahad, Abdul; Ahmad, Hamza; Ullah, Samee title: Importation of SARS‐CoV‐2 Variant B.1.1.7 in Pakistan date: 2021-02-19 journal: J Med Virol DOI: 10.1002/jmv.26869 sha: 37e2aa3c5fec82cdddfb7c6de837c725f0b44c60 doc_id: 974735 cord_uid: w84g6ch6 On December 14 2020, a variant of SARS-CoV-2 characterized as VOC-202012/01 (lineage B.1.1.7) emerged in the United Kingdom [1] with rapid expansion to over 64 countries as of January 27, 2021. This article is protected by copyright. All rights reserved. . Notably, we found the N501Y mutation in the receptor binding domain of spike protein known to escalate viral binding with angiotensin-converting enzyme 2 receptor, increase transmissibility [2] [3] [4] and enables the virus to escape class 1 antibodies. 2, 5 Our sequences MU-NIH-K14 and MU-NIH-K53 also showed a spike protein P618H substitution reported as a key determinant for efficient SARS-CoV-2 transmission 6 and deletion at amino acid 69-70 that has implications for diagnostic assays. 3, 4 Whilst the full implication and functional significance of such variants is yet to be determined, these findings warrant to scale-up the molecular surveillance system in Pakistan to enable early de- ORF1ab C3267T T1001I C3267T T1001I C5388A A1708D C5388A A1708D T6954C I2230T T6954C I2230T 11288 Investigation of novel SARS-CoV-2 variant: variant of concern 202012/01, technical briefing 3. London, United Kingdom: Public Health England Implications of the emergence of a new variant of SARS-CoV-2, VUI-202012/01 Emergence of SARS-CoV-2 B.1.1.7 Lineage -United States Will the emergent SARS-CoV2 B.1.1.7 lineage affect molecular diagnosis of COVID19? Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells